Loganin alleviates myocardial ischemia–reperfusion injury through GLP‐1R/NLRP3‐mediated pyroptosis pathway

Abstract

AbstractMyocardial ischemia–reperfusion (I/R) injury is one of main pathological manifestations of cardiovascular outcomes related to NLRP3 inflammasome‐mediated pyroptosis pathway. Loganin is an iridoid glycoside extracted from traditional Chinese medicines, which has multiple activities. However, the roles and mechanism of loganin in myocardial I/R injury remain largely unknown. The models of myocardial I/R injury were established using I/R‐treated rats or OGD/R‐treated H9C2 cardiomyocytes. Myocardial damage was assessed by TTC and hematoxylin–eosin staining. Pyroptosis‐related marker levels were detected by immunohistochemistry, immunofluorescence and western blotting assays. Cell proliferation was examined via EdU assay. Cell apoptosis was investigated by LDH release and flow cytometry. The integrity of cell membrane was analyzed via Dil staining. GLP‐1R and NLRP3 levels were detected by immunofluorescence and western blotting assays. Our results showed that loganin suppressed I/R‐induced myocardial damage in rats by reducing myocardial infarct, injury and pyroptosis. In addition, loganin attenuated OGD/R‐induced cardiomyocyte apoptosis through increasing cell proliferation and reducing LDH release and apoptotic rate. Loganin also mitigated OGD/R‐induced cardiomyocyte pyroptosis by reducing cell membrane damage and levels of cleaved caspase‐1, IL‐1β and IL‐18. Furthermore, loganin repressed GLP‐1R/NLRP3 pathway activation in OGD/R‐treated H9C2 cardiomyocytes by enhancing GLP‐1R expression and decreasing NLRP3 level. GLP‐1R/NLRP3 activation by GLP‐1R inhibition or NLRP3 overexpression reversed the suppressive effects of loganin on OGD/R‐induced cardiomyocyte pyroptosis. These data indicated that loganin prevented OGD/R‐induced proliferation inhibition, apoptosis and pyroptosis in OGD/R‐treated cardiomyocytes by inhibiting GLP‐1R/NLRP3 activity, indicating the therapeutic potential of loganin in myocardial I/R injury.